对于患有尿血管炎的成年患者的当前治疗选择:范围审查
Anne-Sophie Groleau1, Alexandra Mereniuk2, Jean-Paul Makhzoum3
1Division of Dermatology, Centre Hospitalier Universitaire de Montréal (CHUM), Department of Medicine, Université de Montréal, Montréal, Quebec, Canada.
Journal of the American Academy of Dermatology
|March 29, 2025
概括
审查了状血管炎 (UV) 管理选择,并注意到对这种罕见疾病的数据有限. 治疗范围从轻度病例的抗组胺剂到免疫抑制剂和严重或耐火紫外线的生物药物.
科学领域:
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 状血管炎 (UV) 是一种罕见的小血管血管炎,仅有有限的管理数据.
- 对紫外线的有效治疗策略至关重要,因为它有可能导致系统性参与和发病率.
研究的目的:
- 进行对疹血管炎 (UV) 当前治疗选择的范围审查.
- 根据已发表的文献,综合利用的关于紫外线管理的现有证据.
主要方法:
- 对2000年至2024年1月间发表的文章进行了全面的PubMed搜索.
- 从最初305项已识别的研究中选择了21篇相关文章,以便纳入审查.
主要成果:
- 轻微的皮肤紫外线可以用抗组胺剂和NSAIDs来管理.
- 系统性皮质类固醇被推用于间歇性皮肤紫外线,而氧化,素和达普松是耐火病例的选择.
- 对于持续的症状,免疫抑制剂 (例如,阿扎西奥普林,环胺) 和生物药物 (例如,奥马利祖马布,瑞图西马布) 显示潜在的有效性.
结论:
- 审查发现缺乏高质量的干预研究,大多数数据来自回顾性观察研究和小样本大小.
- 目前对紫外线的治疗数据不足,强调需要进一步研究.
- 本综述概述了UV管理的潜在治疗途径.
更多相关视频
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Myocarditis III: Medical Management
344
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Pericarditis III: Medical Management
592
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
592
Varicose Veins II: Diagnostic Studies and Interprofessional Care
325
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
325
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Nephrotic Syndrome II : Assessment and Medical Management
422
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422


